Complete Genomics' Q4 Revenues Fall 34 Percent; Backlog at 5,800 Genomes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics reported after the close of the market Thursday that its fourth-quarter revenues declined 34 percent, reflecting a previous announcement from the firm that it had missed its 2011 estimate for genome shipments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.